MannKind (MNKD) PT, Estimates Cut at Jefferies; 'Buy' Maintained
Get Alerts MNKD Hot Sheet
Rating Summary:
9 Buy, 3 Hold, 6 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Join SI Premium – FREE
Jefferies analyst Shaunak Deepak lowered estimates and his price target on MannKind (NASDAQ: MNKD) to $9.00 (from $10.00) but is maintaining a Buy rating.
Deepak commented, "Despite early IMS scripts, physician feedback has made us more confident in the long-term sales potential of Afrezza. While we are maintaining our peak estimates, we are now assuming the Afrezza trajectory will take ten years, rather than six. As a result of this more gradual sales ramp, we are lowering lowering our PT from $10 to $9."
The firm cut FY 2015 EPS from $0.41 to ($0.42).
For an analyst ratings summary and ratings history on MannKind click here. For more ratings news on MannKind click here.
Shares of MannKind closed at $5.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Upgrades Taylor Wimpey Plc. (TW/:LN) (TWODF) to Buy
- Zillow Group (ZG) PT Lowered to $53 at BofA Securities
- Alamos Gold Inc. (AGI:CN) (AGI) PT Raised to Cdn$25 at Canaccord Genuity
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!